Issue link: https://www.e-digitaleditions.com/i/1173734
Tablets & Capsules October 2019 37 tion properties. This implies that the batch-to-batch vari- ation of this lactose type is unlikely to cause any variation in formulation development and production. Conclusion To help increase patient safety in a QbD context, it is of utmost important to understand the factors that may show a low variability and, therefore, good consistency in terms of tablet compaction, reflected in the TTS values shown in Figure 5a. The TTS for all eight batches aver- aged around 1.56 to 1.69 megapascals, indicating a high consistency in tableting behavior. The disintegration time, as shown in Figure 5b, was around 60 seconds for all eight placebo batches, indicating good and constant disintegra- Table 2 Thermal properties of eight knowledge-space batches of SuperTab 30GR (n = 3) Product batch DSC—Loss of hydration event DSC—Melting event TGA (% w/w) Onset (°C) Peak (°C) Enthalpy(J/g) Onset (°C) Peak (°C) 1 139 144 135±5 213 220 4.6 2 140 144 135±4 212 220 4.5 3 139 144 138±4 213 220 4.5 4 140 144 135±4 212 220 4.5 5 140 144 139±3 213 220 4.5 6 140 143 143±1 213 220 4.5 7 140 144 145±1 212 220 4.5 8 140 143 140±1 213 220 4.5 Figure 4 Score plot showing eight batches selected for further investigation Hotelling's T 2 95% confidence limit t[2] 4 3 2 1 0 -1 -2 -3 -4 -5 t[1] -4 -3 -2 -1 0 1 2 3 4 No ID ID R 2 x[1] = 0.158 R 2 x[2] = 0.14

